Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Clinical implications of determination of plasma haloperidol levels.

Santos JL, Cabranes JA, Almoguera I, Ramos JA, Vazquez C, Angeles F.

Acta Psychiatr Scand. 1989 Apr;79(4):348-54.

PMID:
2735205
[PubMed - indexed for MEDLINE]
2.

Haloperidol plasma levels and acute clinical change in schizophrenia.

Coryell W, Kelly M, Perry PJ, Miller DD.

J Clin Psychopharmacol. 1990 Dec;10(6):397-402.

PMID:
2286709
[PubMed - indexed for MEDLINE]
3.

Determination of plasma haloperidol concentrations by radioreceptor assay in schizophrenia: clinical utility.

Santos JL, Ramos JA, Prieto P, Almoguera I, Vazquez C, Rubio ME, Cabranes JA.

Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(6):917-25.

PMID:
2813809
[PubMed - indexed for MEDLINE]
4.

Serum haloperidol concentration and clinical response in schizophrenia.

Kirch DG, Bigelow LB, Korpi ER, Wagner RL, Zalcman S, Wyatt RJ.

Schizophr Bull. 1988;14(2):283-9.

PMID:
3201181
[PubMed - indexed for MEDLINE]
Free Article
5.

Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.

Volavka J, Cooper TB, Meisner M, Bitter I, Czobor P, Jaeger J.

Psychopharmacol Bull. 1990;26(1):13-7.

PMID:
2371368
[PubMed - indexed for MEDLINE]
6.

Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.

Santos JL, Cabranes JA, Vazquez C, Fuentenebro F, Almoguera I, Ramos JA.

Biol Psychiatry. 1989 Aug;26(4):381-8.

PMID:
2669981
[PubMed - indexed for MEDLINE]
7.

RBC and plasma levels of haloperidol and clinical response in schizophrenia.

Smith RC, Vroulis G, Shvartsburd A, Allen R, Lewis N, Schoolar JC, Chojnacki M, Johnson R.

Am J Psychiatry. 1982 Aug;139(8):1054-6.

PMID:
7091432
[PubMed - indexed for MEDLINE]
8.

Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.

Smith RC, Baumgartner R, Misra CH, Mauldin M, Shvartsburd A, Ho BT, DeJohn C.

Arch Gen Psychiatry. 1984 Nov;41(11):1044-9.

PMID:
6497566
[PubMed - indexed for MEDLINE]
9.

[Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].

Dutoit D, Thomas P, Leroux JM, Vaiga G, Pommery J, Cottencin O, Erb F, Goudemand M.

Encephale. 1995 Nov-Dec;21(6):417-24. French.

PMID:
8674466
[PubMed - indexed for MEDLINE]
10.

Haloperidol plasma levels and dose optimization.

Coryell W, Miller DD, Perry PJ.

Am J Psychiatry. 1998 Jan;155(1):48-53.

PMID:
9433338
[PubMed - indexed for MEDLINE]
11.

Haloperidol: therapeutic window in schizophrenia.

Palao DJ, Arauxo A, Brunet M, Bernardo M, Haro JM, Ferrer J, Gonzalez-Monclus E.

J Clin Psychopharmacol. 1994 Oct;14(5):303-10.

PMID:
7806684
[PubMed - indexed for MEDLINE]
12.

Level of haloperidol in plasma is related to electroencephalographic findings in patients who improve.

Czobor P, Volavka J.

Psychiatry Res. 1992 May;42(2):129-44.

PMID:
1631250
[PubMed - indexed for MEDLINE]
13.

Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia.

Balant-Gorgia AE, Eisele R, Balant L, Garrone G.

Eur Arch Psychiatry Neurol Sci. 1984;234(1):1-4.

PMID:
6489392
[PubMed - indexed for MEDLINE]
14.

Haloperidol plasma levels and clinical response: a therapeutic window relationship.

Van Putten T, Marder SR, Mintz J, Poland RE.

Am J Psychiatry. 1992 Apr;149(4):500-5.

PMID:
1554036
[PubMed - indexed for MEDLINE]
15.

Total and free plasma neuroleptic levels in schizophrenic patients.

Tang SW, Glaister J, Davidson L, Toth R, Jeffries JJ, Seeman P.

Psychiatry Res. 1984 Dec;13(4):285-93.

PMID:
6596586
[PubMed - indexed for MEDLINE]
16.

Therapeutic effects of bromperidol on the five dimensions of schizophrenic symptoms.

Yasui-Furukori N, Kondo T, Ishida M, Furukori H, Suzuki A, Kaneko S, Inoue M, Otani K.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):53-7.

PMID:
11853119
[PubMed - indexed for MEDLINE]
17.

Relationship of serum haloperidol levels to clinical response in schizophrenic patients.

Magliozzi JR, Hollister LE, Arnold KV, Earle GM.

Am J Psychiatry. 1981 Mar;138(3):365-7.

PMID:
7468835
[PubMed - indexed for MEDLINE]
18.

Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia.

Smith RC, Baumgartner R, Shvartsburd A, Ravichandran GK, Vroulis G, Mauldin M.

Psychopharmacology (Berl). 1985;85(4):449-55.

PMID:
2862652
[PubMed - indexed for MEDLINE]
19.

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.

Goff DC, Posever T, Herz L, Simmons J, Kletti N, Lapierre K, Wilner KD, Law CG, Ko GN.

J Clin Psychopharmacol. 1998 Aug;18(4):296-304.

PMID:
9690695
[PubMed - indexed for MEDLINE]
20.

Haloperidol plasma level after a test dose as predictor for the clinical response to treatment in acute schizophrenic patients.

Louza Neto MR, Müller-Spahn F, Rüther E, Scherer J.

Pharmacopsychiatry. 1988 Sep;21(5):226-31.

PMID:
3227054
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk